由Trypanosoma cruzi细胞外囊泡和免疫复合体诱导的心脏变化
Alberto Cornet-Gomez1, Francisco O'Valle2,3,4, José M Garrido2,5,6
1Department of Parasitology, Biochemical and Molecular Parasitology Group CTS-183, and Institute of Biotechnology, University of Granada, Granada, Spain.
PLoS neglected tropical diseases
|July 7, 2025
概括
来自Trypanosoma cruzi的细胞外囊泡 (EV),与IgG形成免疫复合体,在小鼠中诱导心脏损伤,模仿查加斯病心肌病变. 这些EV被确定为潜在的毒性因素,有助于查加斯病的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 心脏病学 心脏病学
背景情况:
- 由Trypanosoma cruzi引起的查加斯病 (CD) 在慢性阶段往往导致严重的心脏并发症.
- 驱动夏加斯心肌病的确切机制仍然不完全理解,寄生虫因素和宿主免疫反应的作用被提出.
- 细胞外囊泡 (EVs) 涉及寄生虫与宿主通信和免疫调节,具有作为诊断工具的新兴潜力.
研究的目的:
- 调查Trypanosoma cruzi释放的EVs及其与抗T. cruziIgG的免疫复合体 (ICs) 在心脏变化的发展中的作用.
- 在小鼠模型中评估EVs和ICs对心脏功能,蛋白质表达和炎症标志物的影响.
主要方法:
- 在21天的时间里,小鼠被静脉注射了EVs和ICs (EVs-IgG).
- 评估了自身抗体的存在,心电图 (ECG),心脏组织病理学,以及心脏中的蛋白质和细胞因子表达.
- 测量了血清B型性尿素 (BNP) 的水平.
主要成果:
- EVs和ICs诱导了心电图的改变,包括心率和PR间隔的变化.
- 观察到心脏结构变化和关键蛋白质 (连素43,氨酸,丁氨酸) 的表达减少.
- 改变了VCAM-1的表达,心脏中的细胞因子概况发生了变化,血清BNP水平增加,表明心脏受损.
结论:
- 由Trypanosoma cruzi产生的EV和它们与IgG形成的免疫复合体可以诱导类似于查加斯病的心脏变化.
- 这项研究强调了EVs在查加斯病病原性中的重要作用.
- 在查加斯病的发展和进展中,EV应该被认为是关键的毒性因素.
相关概念视频
Endocarditis II: Clinical Features of Infective Endocarditis
28
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
28
Myocarditis I: Introduction
35
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
35
Myocarditis II: Clinical Features and Diagnostic Tests
31
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
31
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Rheumatic Heart Disease I: Introduction
52
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
52
Cardiomyopathy III: Hypertrophic Cardiomyopathy
61
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
61


